Literature DB >> 29234194

An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver Disease.

Mayank Jain1, Joy Varghese1, Tom Michael1, Chandan Kumar Kedarishetty1, Balajee G1, Subramanian Swaminathan1, Jayanthi Venkataraman1.   

Abstract

BACKGROUND: End stage liver disease leads to immune dysfunction which predisposes to infection. There has been a rise in antibiotic resistant infections in these patients. There is scanty data f from India or idea regarding the same. AIM OF THE STUDY: The present study was undertaken to determine the type of infection acquired and the prevalence of antibiotic resistant infections in cirrhotic patients at a tertiary referral center in South India.
MATERIALS AND METHODS: In this retrospective study, all consecutive cirrhotic patients hospitalized between 2011 and 2013 with a microbiologically-documented infection were enrolled. Details of previous admission and antibiotics if received were noted. In culture positive infections, the source of infection (ascites, skin, respiratory tract: sputum/endotracheal tube aspirate, pleural fluid; urine and blood) and microorganisms isolated and their antibiotic susceptibility was noted.
RESULTS: A total of 92 patients had 240 culture positive samples in the study period. Majority were Klebseilla followed by Escherichia coli and Enterococcus in nosocomial and health care associated infections. However, Enteroccocus was followed by E. coli and Klebsiella in community acquired infections. The antibiotic sensitivity pattern was analyzed for the major causative organisms such as E. coli, Klebsiella and Enterococcus. Most common resistant strains were extended spectrum beta lactamase producing enterobacteriacae (ESBL) followed by carbapenemase producing Klebsiella and methicillin resistant Staphylococcus aureus.
CONCLUSION: Noscomial infection is the most common type, with Klebsiella and E. coli and there is significant rise in ESBL producing organism.

Entities:  

Keywords:  CAI, community-acquired infection; CPK, carbapenemase producing Klebsiella; ESBL, beta lactamase producing enterobacteriacae; ESLD, end stage liver disease; HAI, hospital acquired infection; MRSA, methicillin-resistant Staphylococcus aureus; SBP, spontaneous bacterial peritonitis; TGC, third generation cephalosporins; UTI, urinary tract infection; VRE, vancomycin-resistant Enterococcus; antibiotics; cirrhosis liver; microbial resistance

Year:  2017        PMID: 29234194      PMCID: PMC5715483          DOI: 10.1016/j.jceh.2017.05.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  19 in total

Review 1.  Management of bacterial infections in cirrhosis.

Authors:  Javier Fernández; Thierry Gustot
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

2.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

Authors:  Javier Fernández; Juan Acevedo; Miriam Castro; Orlando Garcia; Carlos Rodríguez de Lope; Daria Roca; Marco Pavesi; Elsa Sola; Leticia Moreira; Anibal Silva; Tiago Seva-Pereira; Francesco Corradi; Jose Mensa; Pere Ginès; Vicente Arroyo
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

3.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

4.  Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge.

Authors:  Salvatore Piano; Antonietta Romano; Silvia Rosi; Angelo Gatta; Paolo Angeli
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 2.566

Review 5.  Renal failure and cirrhosis: a systematic review of mortality and prognosis.

Authors:  Giuseppe Fede; Gennaro D'Amico; Vasiliki Arvaniti; Emmanuel Tsochatzis; Giacomo Germani; Dimosthenis Georgiadis; Alberto Morabito; Andrew Kenneth Burroughs
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

6.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

7.  High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.

Authors:  Puneeta Tandon; Angela Delisle; Jeffrey E Topal; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-17       Impact factor: 11.382

Review 8.  New determinants of prognosis in bacterial infections in cirrhosis.

Authors:  Juan Acevedo; Javier Fernández
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 9.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis.

Authors:  A Umgelter; W Reindl; M Miedaner; R M Schmid; W Huber
Journal:  Infection       Date:  2009-01-23       Impact factor: 3.553

View more
  5 in total

Review 1.  Overview of Complications in Cirrhosis.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-05-14

2.  Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Shift in the Microbial Pattern? A Retrospective Analysis.

Authors:  Raquel Pimentel; Jorge Leitão; Carlos Gregório; Lélita Santos; Armando Carvalho; Pedro Figueiredo
Journal:  GE Port J Gastroenterol       Date:  2021-08-24

3.  Cellulitis in liver cirrhosis - a series of 25 cases from southern India.

Authors:  Uday Sanglodkar; Mayank Jain; Dinesh Jothimoni; Subhashree Parida; Balajee G; Jayanthi Venkataraman
Journal:  Clin Exp Hepatol       Date:  2018-09-10

4.  Risk factors predicting nosocomial, healthcare-associated and community-acquired infection in spontaneous bacterial peritonitis and survival outcome.

Authors:  Mayank Jain; Uday Sanglodkar; Jayanthi Venkataraman
Journal:  Clin Exp Hepatol       Date:  2019-05-13

5.  Clinical audit to determine efficacy of daily infusion of low dose of 20% albumin in combination with antibiotics in patients with spontaneous bacterial peritonitis.

Authors:  Uday Sanglodkar; Mayank Jain; Joy Vargese; Chandankumar Kedarisetty; Jayanthi Venkataraman
Journal:  Clin Exp Hepatol       Date:  2019-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.